Koo, O. M. Y., Rubinstein, I., & Önyüksel, H. (2010). Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis.
Styl ChicagoKoo, Otilia May Yue, Israel Rubinstein, a Hayat Önyüksel. Actively Targeted Low-Dose Camptothecin As a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis. 2010.
Citace podle MLAKoo, Otilia May Yue, Israel Rubinstein, a Hayat Önyüksel. Actively Targeted Low-Dose Camptothecin As a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis. 2010.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..